Events Partner Content TCR-based Therapeutics for Solid Tumors Summit Hear from experts at the TCR based Therapeutics Summit
Events Partner Content Multi-Functional Cell Therapies Summit Development with Next-Generation Cell Therapies
News Pfizer's Tukysa greenlit for earlier use in breast cancer Pfizer gets FDA approval for maintenance use of its oral HER2 inhibitor Tukysa in breast cancer, which it hopes will unlock renewed sales growth.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
